CLINICAL RESEARCH
10.4244/EIJY15M01_01
•
Mar 20, 2015
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco DJ, Dawkins K
free
CLINICAL RESEARCH
10.4244/EIJY15M01_07
•
Mar 20, 2015
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study
Thomas M, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood P, Dawkins K
free
CLINICAL RESEARCH
10.4244/EIJY14M08_07
•
Mar 20, 2015
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K, Van den Branden B, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing BJ, Suttorp MJ
free
CLINICAL RESEARCH
10.4244/EIJY14M08_11
•
Mar 20, 2015
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial
Löwik M, Lam MK, Sen H, Tandjung K, van Houwelingen K, de Man F, Stoel M, Louwerenburg H, Linssen GCM, Doggen CJM, von Birgelen C
free
CLINICAL RESEARCH
10.4244/EIJY15M01_04
•
Mar 20, 2015
Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation
Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer J-C, Garachemani A, Moschovitis A, Meier B, Jüni P, Windecker S
free
CLINICAL RESEARCH
10.4244/EIJV10I11A218
•
Mar 20, 2015
Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial
Nakatani S, Onuma Y, Ishibashi Y, Muramatsu T, Iqbal J, Zhang Y-J, van Geuns R, Ormiston J, Serruys PW
free
CLINICAL RESEARCH
10.4244/EIJY14M04_11
•
Mar 20, 2015
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys PW
free
TECHNICAL REPORT
10.4244/EIJV10I11A220
•
Mar 20, 2015
A novel homemade snare, safe, economical and size-adjustable
Yokoi K, Sumitsuji S, Kaneda H, Siegrist P, Okayama K, Ide S, Mizote I, Kumada M, Kuroda T, Tachibana K, Sakata Y, Nanto S
free
CLINICAL RESEARCH
10.4244/EIJY15M02_10
•
Mar 20, 2015
Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy
Picci A, Limbruno U, Andò G, Brugaletta S, Cortese B, De Carlo M, Garcia-Garcia H, Palmieri C, Regar E, Rigattieri S, Sardella G, Zimarino M, Valgimigli M
free
CLINICAL RESEARCH
10.4244/EIJY14M08_16
•
Mar 20, 2015
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K, Koo B, Waseda K, Nakatani D, Yock P, Whitbourn R, Worthley S, Ormiston J, Webster M, Wilkins G, Honda Y, Meredith I, Fitzgerald P
free
Showing
3256
to
3270
of
5321
results
